(59) reported the progressive accumulation of depleted CD8+ PD-1 T cells in NASH-affected livers, and elimination of enriched CD8+ PD-1 T cells reduced liver injury and HCC incidence. The gene discussed is CD8A; the disease is metabolic dysfunction-associated steatohepatitis.